Onkologiezentrum Berner Oberland
About Onkologiezentrum Berner Oberland
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
ETOP IBCSG Partners Foundation
4
Alliance Foundation Trials, LLC.
1
Clinical Trials at Onkologiezentrum Berner Oberland
During the past decade, Onkologiezentrum Berner Oberland conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on
average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Testing of Drugs Erlotinib and Docetaxel in Lung Cancer Patients Classified Regarding Their Outlook Using VeriStrat®.
2012-08-01
2015-12-01
Completed
81
Survival imProvement in Lung cancEr iNduced by DenOsUmab theRapy
2015-01-06
2020-02-29
Completed
514
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
2014-12-04
2028-12-01
Active, not recruiting
518
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Onkologiezentrum Berner Oberland"
#1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Austrian Breast & Colorectal Cancer Study Group" with 1 trials as a collaborator and "Biodesix, Inc." with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were
collaborators in the rest 11 trials.
Clinical Trials Conditions at Onkologiezentrum Berner Oberland
According to Clinical.Site data, the most researched conditions in "Onkologiezentrum Berner Oberland" are
"Breast Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Early Breast Cancer" (1 trials), "Lung Cancer" (1 trials) and "Lung Cancer Non-small Cell Stage IV" (1 trials). Many other conditions were trialed in "Onkologiezentrum Berner Oberland" in a lesser frequency.
Clinical Trials Intervention Types at Onkologiezentrum Berner Oberland
Most popular intervention types in "Onkologiezentrum Berner Oberland" are "Drug" (4 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Erlotinib" (2 trials), "Bevacizumab" (1 trials), "Denosumab" (1 trials), "Docetaxel" (1 trials) and "Endocrine therapy interruption" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Onkologiezentrum Berner Oberland
The vast majority of trials in "Onkologiezentrum Berner Oberland" are
4 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Onkologiezentrum Berner Oberland
Currently, there are NaN active trials in "Onkologiezentrum Berner Oberland".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Onkologiezentrum Berner Oberland,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Onkologiezentrum Berner Oberland, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".